key: cord-1006371-b6efhpev
authors: Singh, Vishwajeet; Singh, Mukul Kumar
title: Acute Kidney Injury in COVID-19: a Brief Review
date: 2021-04-23
journal: Indian J Surg
DOI: 10.1007/s12262-020-02697-8
sha: 710b4f75fd2ab81dc6ec39cdbff7eeddbabff706
doc_id: 1006371
cord_uid: b6efhpev

The contemporary evolution of the coronavirus disease 2019 (COVID-19) outbreak from the Wuhan, China, with a high rate of transmission will act the global medical emergency with immense morbidity and mortality rate across the world. The cell entry of COVID-19 via angiotensin-converting enzyme 2 receptor (ACE-2 receptor) will damage the respiratory system by the cytopathic effect induced by replication of the virus genome in the host and respond respiratory failure with an elevation of cytokine factor-like interleukin (IL) IL-6, IL-8, tumor necrosis factor-alpha (TNF-alpha), etc. However, the lung-kidney cross talk will evidence the activation of molecular mechanisms from pro-inflammatory cytokines and concerned with kidney damage, though the elevated rate of ACE-2 receptor in the kidney will enhance the possibility of mortality with consideration of acute kidney injury. This review provides relevant information which suggests the rate of mortality in COVID-19 patient associated with acute kidney injury (AKI) which lacks critical monitoring of kidney function with a clinical consideration of intervention to avoid kidney damage in the initial stage of the disease.

The novel coronavirus 2019 (COVID-19) resembled with the severe acute respiratory syndrome coronavirus (SARS-CoV) outbreak from the Wuhan, Hubei province, China. This virus belongs to the Coronaviridae family associated with acute respiratory syndrome. In the past years, the epidemic caused by COVID-19 family members was severe acute respiratory syndrome (SARS) and Middle Eastern Respiratory Syndrome (MERS), whereas in March 2020, the WHO characterizes COVID-19 as a pandemic with the highest morbidity and mortality rate across the world. COVID-19 primarily targets the respiratory system with a clinical outcome of shortening in a breath.

The genome of SARS-CoV and COVID-19 identical to each other depends on the open reading frame of replication which is about 94.4% similar [1] . However, the S gene encodes spike protein for attachment with ACE-2 receptor of targeted cells having receptor function against the renninangiotensin system, whereas TMPRSS2 protease which priming the S protein and induces viral and cellular membrane fusion [2] . The pathological alteration in targeted organs was associated with systemic respiratory failure mediated by replication of the viral genome and destructive immune response.

The changes related to SARS-CoV does not confine to the respiratory system, pervasive to organs identified by the murine monoclonal antibody for SARS-CoV and probe designed for SARS-CoV RNA, which detected SARS-CoV in the lung, stomach, small intestine, distal convoluted renal tubule, etc. [3] . Moreover, the study of 54 patients affected by COVID-19 classify in critical and severe type patients, results as kidney will be the most affected organ after heart and majorly found in critical type patients [4] . However, the conflicting data that defines the lung injury is susceptible to kidney function. In this review, we are focusing on the pathophysiology of COVID-19 that induces lung injury and its effect on the kidney associated with the rate of mortality induced by acute kidney injury.

The ACE-2 receptor is a primary site of interaction for COVID-19. The localization of ACE-2 in macrophages, type II alveolar cells, and tracheal cells of the lung [5] induces the access of viral genome in cells. In addition, further experimental studies depict the knockout of the ACE-2 receptor in mice model to reduce the replication of the COVID-19 viral genome [6] . This experimental fact illustrates that ACE-2 is a primary requirement for the entry of the viral genome. However, contradiction among the primary receptor arises with the identification of secondary receptor CD209L identified in a Chinese culture hamster ovary [7] . After COVID-19 infection, the hyperinflammatory response was initiated and associated with an elevation in serum cytokine and inflammatory markers such as ferritin, D-dimer, and C-reactive protein.

Moreover, the profiling of cytokines in COVID-19 patients represents an elevation in TNF, cytokines (IL-6, IL-7, and IL-2), and chemokines. Thus, the histology of lung biopsy sample illustrates bilateral diffuse alveolar damage with cellular fibromyxoid and formation of a hyaline membrane which indicates acute respiratory distress syndrome [8] .

The lung damage caused by pneumonia and related disorder COVID-19 were associated with the multiple organ failure majorly coupled with cardio-renal malfunction, although the baseline functioning of organs depends on oxygen metabolism. The renal function associated with an exchange of PO2 and PCo2, thus fluid retention dependent on the functioning of lungs, the reduction in oxygen tension from 54 mmHg to 30 mmHg depicts the alleviation in diuresis with a significant decline in Glomerular filtration rate (GFR) and renal plasma flow (RPF) throughout the hypoxia, created by lung dysfunctioning [9] .

Meanwhile, impairment of pulmonary function due to COVID-19 causes the acute hypercapnic acidosis which affects the renal function by increasing glomerular filtration rate (GFR) with a change in concentration of tubular fluid through excretion of urinary sodium and results in elevation of plasma renin by effecting renin-angiotensin system with controversy on impairment of renal function [10] . In a study by Bratel et al. [11] which concluded that long term lung dysfunction induced hypercapnia responsible for the failure of renal function by alleviating GFR.

The lung injury of COVID-19 patient classically was associated with acute respiratory distress syndrome (ARDS) which requires a ventilator for breathing. However, natural breathing creates negative pressure in the lung to pursue breathing. But ventilators create artificial positive pressure and affect the intrathoracic pressure which decreases the cardiac output and decreases the GFR. Moreover, lung injury induces a cytokine-mediated response, similar to COVID-19 induce cytokine, which generates pro-inflammatory markers such as TNF-alpha, IL-6, IL-8, and IL-beta and affects the renal function that induces AKI [12] .

The AKI patients effected with COVID-19 having a high rate of mortality which depicts the function of the kidney is directly proportional to lung function, as an outcome it enhances the rate of lung damage. The relationship between the kidney and lung characterizes the electrolyte balance and regulates the acid-base balance responsible for the transfer of oxygen to the tissue. The co-relation among oxygen transfer in the tissue illustrates that the kidney is directly dependent on the function of cardiac output and lung function. In addition, production of erythropoietin regulates the oxygen-carrying capacity in the body. Though, clinical studies verify disturbance in nitrogenous waste affected by AKI gives a negative clinical outcome by alleviate the rate of monoxide diffusion interpret the marker of pulmonary function [13] .

Moreover, AKI curbs the respiratory system by pulmonary edema which might be cardiogenic. The cardiogenic pulmonary edema arises from the damaged cardiac function. The hydrostatic force and oncotic force are responsible for steady fluid flow inside the capillary lumen, whereas impaired cardiac response elevates the hydrostatic, and oncotic force leads to the invasion of fluid from capillary to alveolar site. The normal kidney function inhibits the process by dieresis [14, 15] . Meanwhile, normal kidney function regulates the acid-base firmness by establishing equilibrium among bicarbonate, carbonic acid, and carbon dioxide. Fluctuation in the pH of oxygenated blood initiates the deviation of equilibrium which is critical to lung function. Thus, reabsorption of bicarbonate by kidney controls the deviation of equilibrium en route to acidosis and similar to alkalosis.

AKI patients upregulate the expression of cytokine which induce the lung damage, the data from animal and patient studies suggest that the IL-6 associated with CXCL1 chemokine induce lung injury in AKI by increasing the endothelial CXCL1 production and promotes the neutrophil accretion by upregulation of IL-8 through IL-6 receptor using gp130 on the endothelial cell of the lungs [16] . Although, certain inflammatory mediators identified with their mode of mechanism which induces lung injury see Table 1 . In addition, 66 genes were identified in the ischemic mouse model which liable for apoptosis, out of them 6 stands for tumor necrosis factor receptor and lead to AKI mediate pulmonary apoptosis. Thus, cas-3 mediated apoptotic pathway induces lung injury that takes place at endothelial cells [17] . This evidence represents that the survival analysis of kidney dysfunction patients with COVID-19 had a 5-fold higher mortality risk [18] and AKI brings out the distant organ injury like lung damage [19] .

The ACE-2 responsible for rennin angiotensin regulation depends on the conversion of angiotensin II into angi(1-7) and interacts with the Mas receptor. ACE-2 is a homolog of ACE (AT1R) receptors. Moreover, during the development of kidney, the expression of ACE-2 upregulated [27] and promote sodium and water excretion. Thus, ACE-2 is not solely curbed to the COVID-19 primary targeting site. However, deviation in developmental renin angiotensin system (RAS) is associated with the downregulation of ACE-2 in tubule due to hypertension [28] . The localization of ACE-2 was found within the vascular tunica media layer, whereas ACE was found in the endothelial layer. A study suggests that the administration ACE blocker given for cases with comorbidities such as hypertension results in overexpression of ACE-2 in renal arterioles and a decrease in ACE/ACE-2 ratio marked by mRNA data [29] . Although, the clinical data from the study shows that throughout the initial phase of viral infection, patients having signs of kidney dysfunction identified which show 59%(Proteinuria), 44%(hematuria), 14% (Upregulation of urea) and 10% increased level of creatinine. In the later phase of infection, it turns into worst with the reducing level of albumin in COVID-19 patients [18] . Hence, the abundance of renal ACE-2 receptor can be liable for COVID-19 induced kidney dysfunction due to maximum exposure.

In addition, MERS-CoV belongs to a family of coronavirus and associated with kidney dysfunction. The replication of viral genome in the host significantly altered the expression of genes. Thus, the upregulation of Smad7 and FGF2 (fibroblast growth factor 2) induces cas-3 mediated apoptosis and result in kidney dysfunction with lung injury [29] . Furthermore, in another study, the overexpression of Smad7 by adenoviral in primary cultured rat mesangial cells depicts the cas-3 mediated apoptosis followed by TGF-β [30] . Moreover, COVID-19 induces tubular pathogenesis by CD68+ macrophage and C5b-9 complement which directly infects the human kidney [31] . This evidence suggests that COVID-19 can induce smad7 mediated cas-3 apoptosis and affect the GFR which results in kidney dysfunction.

Patients with COVID-19 with acute kidney injury exhibit the lung as the primary site of involvement which subsequently leads to kidney-lung cross talk. The COVID-19 angiotensinconverting enzyme-2 receptor not solely presents in the respiratory system, although expression of angiotensin-converting enzyme 2 receptor elevated in the kidney; thus, it represents renal tubular damage. Therefore, mortality rate is slightly higher in COVID-19 patients associated with acute kidney injury and defines a negative marker for survival. In addition, proteinuria, hematuria, as well as blood urea nitrogen and creatinine are considered for the extant of kidney activity in COVID-19 patients. The emphasis should be on very close observation of kidney functions with the involvement of potential cytokine inhibitor to evade the enforcement of inflammatory cytokine from lung damage to alleviate the mortality of COVID-19-associated acute kidney injury patients.

Data Availability Not Applicable.

Conflict of Interest The authors declare that they have no conflict of interest.

Ethics Approval Not required, the manuscript does not contain clinical study or patient data. IL-8 Activated by IL-6 mediated gp130, responsible for the accumulation of neutrophil and inflammation in the lung [26] NFκB nuclear factor kappa B, TNF1 tumor necrosis factor receptor 1, IL interleukin, AKI acute kidney injury, TLR4 Toll-like receptor 4, HMGB1 high mobility group box 1, gp130 glycoprotein 130

Consent to Participate Not applicable, the review article does not contain any patient data.

The authors transfer to Springer the nonexclusive publication rights, and they warrant that their contribution is original.

Code Availability Not Applicable.

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response

Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways

Retrospective analysis of laboratory testing in 54 patients with severe-or critical-type 2019 novel coronavirus pneumonia. Laboratory investigation

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Renal function in respiratory failure: effects of hypoxia, hyperoxia, and hypercapnia

Classical renin-angiotensin system in kidney physiology

Renal function in hypoxaemic chronic obstructive pulmonary disease: effects of long-term oxygen treatment

Mechanical ventilation and acute renal failure

Pulmonary function in uremic patients on long-term hemodialysis

Uremic lung

Studies on electrolytefluid retention. I. Uremic lung, fluid lung? On pathogenesis and therapy; a preliminary report

Circulating IL-6 mediates lung injury via CXCL1 production after acute kidney injury in mice

Kidney ischemia-reperfusion injury induces caspasedependent pulmonary apoptosis

Caution on kidney dysfunctions of COVID-19 patients

Alpha-melanocytestimulating hormone inhibits lung injury after renal ischemia/reperfusion

TNFR1-dependent pulmonary apoptosis during ischemic acute kidney injury

Lung endothelial cell apoptosis during ischemic acute kidney injury

Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy

Lung T lymphocyte trafficking and activation during ischemic acute kidney injury

The high-mobility group protein B1-Toll-like receptor 4 pathway contributes to the acute lung injury induced by bilateral nephrectomy

Serum interleukin-6 and interleukin-8 are early biomarkers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study

Developmental expression of ACE2 in the SHR kidney: a role in hypertension?

Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic

Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan

Smad7 mediates transforming growth factor-beta-induced apoptosis in mesangial cells

Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection

Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations